Monoscot TZ 1.125gm Injection
Marketer
Scott Edil Pharmacia Ltd
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Monoscot TZ 1.125gm Injection
TZ Injection 1.125g, a dual-action antibiotic, combats diverse bacterial infections by hindering microbial proliferation. Administration must be strictly under medical guidance. Complete the prescribed treatment regimen, regardless of symptom improvement; premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Allergic reactions (rash, itching, swelling, respiratory distress) demand urgent medical care. Inform your physician of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While driving ability is usually unaffected, refrain from driving if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and sufficient hydration are crucial for optimal recovery. Your doctor may order blood tests and other assessments to monitor treatment response.
Primary Ingredients of Monoscot TZ 1.125gm Injection
No information provided. Please provide the text you wish to be rephrased.
Uses of Monoscot TZ 1.125gm Injection
Infections caused by bacteria
Major Benefits of Monoscot TZ 1.125gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Monoscot TZ 1.125gm Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Monoscot TZ 1.125gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Monoscot TZ 1.125gm Injection works:
Ceftriaxone and Tazobactum, the components of Monoscot TZ 1.125gm Injection, act synergistically. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, thereby hindering bacterial growth. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Monoscot TZ 1.125gm Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Monoscot TZ 1.125gm is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or absent harm to offspring; nonetheless, clinical data in pregnant women remain scarce.
Breast feedingCAUTION
Administering Monoscot TZ 1.125gm Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Monoscot TZ 1.125gm Injection might induce drowsiness, blurred vision, or dizziness. Refrain from operating a vehicle if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Monoscot TZ 1.125gm Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering 1.125-gram Monoscot TZ injections to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician. Dosage alteration for Monoscot TZ 1.125-gram injections is unnecessary for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Monoscot TZ 1.125gm Injection :
Should you forget a scheduled dose of Monoscot TZ 1.125gm Injection, seek medical advice.
Facts to Know About Monoscot TZ 1.125gm Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently